Sign In
Get Clay Free →

Suggestions

    Phil Leung

    Senior Partner at Bain & Company

    Phil Leung is a Senior Partner at Bain & Company, where he leads the Asia-Pacific Mergers & Acquisitions (M&A) practice and heads the Greater China Healthcare & Life Sciences practice. He has been with Bain since 1996, accumulating extensive experience in growth strategy, transformation programs, and joint ventures across Asia-Pacific, particularly in Greater China.12

    Professional Background

    • Expertise: Phil specializes in M&A, corporate finance, and strategy. He has advised both multinational and local companies on various projects, including overseas M&A initiatives in sectors such as healthcare, financial services, and consumer goods.12
    • Publications: He is a prolific author, contributing articles to notable publications like the Harvard Business Review and Forbes, focusing on the M&A landscape in Asia.2

    Education

    • Phil holds an MBA from Harvard Business School and an undergraduate degree in business administration from the University of California, Berkeley, where he graduated with highest honors.12

    Recent Contributions

    Phil has been involved in various significant discussions and reports on M&A strategies in Asia-Pacific. His insights have been featured in webinars and reports addressing topics like the role of M&A in driving growth for consumer products companies in the region.1

    Current Role

    Based in Shanghai, Phil continues to influence the consulting landscape through his leadership at Bain, contributing to strategic decisions that affect both local and international markets.2

    Highlights

    Dec 19 · bain.com
    Philip Leung: China Outbound M&A | Bain & Company
    Dec 20 · bain.com
    Philip Leung: China Outbound M&A - Bain & Company
    Nov 19 · bain.com
    Philip Leung: Rules for Outbound M&A in China - Bain & Company

    Related Questions

    What are some of Phil Leung's most notable M&A projects in Asia-Pacific?
    How has Phil Leung's work impacted the healthcare industry in Greater China?
    What are Phil Leung's key insights on the future of M&A in Asia?
    How does Phil Leung's experience at Bain & Company compare to other global consulting firms?
    What are the main challenges Phil Leung has faced in his M&A work in China?